Pharmaceutical Advertising
United Kingdom
01 September 2025
Colm Murphy leads Cooley (UK) LLP‘s patent offering, which is adept at navigating licensing and collaboration agreements for emerging life sciences and biotech innovators, as well as advising those who invest into the sectors. The team, which includes patent strategy and application specialist Tanya Heare-Rowlands and partnership and collaboration agreement-focused Joe Sandys, also handles the IP elements of M&A.
Legal 500 Editorial commentary
Key clients
- Ligand Pharmaceuticals
- Illumina, Inc.
- Kohlberg Kravis Roberts
- Hummingbird Biosciences
- Mestag
- Anocca
- Apollo Therapeutics
- Bavarian Nordic
- Adcendo ApS
- AviadiBio
- Forbion
Work highlights
Advised Ligand Pharmaceuticals on the IP-related aspects of its acquisition of Apeiron Ag for $100m.
Advised KKR on the IP-related aspects in its joint acquisition, together with Impilo, of Immedica Pharma.
Advising Hummingbird on a licence out of patents and know how covering its ADC technology to US life sciences company, Endeavor.
Practice head
Colm Murphy
Other key lawyers
Tanya Heare-Rowlands; Joe Sandys